Search | Clinical Trials Finder

Conditions: Chronic Low-back Pain
Interventions: Standardized Education, Telerehabilitation; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 434 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Baltimore, Maryland • Salisbury, Maryland

Conditions: Clostridioides Difficile Infection Recurrence
Interventions: Participants that are undergoing standard of care antibiotic treatment for their second C. Diff infection will be followed for 8 weeks after completing antibiotic treatment.; Other
Lead sponsor: Bactolife A/S; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Macular Edema Associated With Diabetes Mellitus
Interventions: Standard of Care, Macugen; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 317 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 28
States / cities: Phoenix, Arizona • Tucson, Arizona • Los Angeles, California + 24 more

Conditions: HIV-1-infection
Interventions: Care Navigator, Multicomponent HIV Service Package; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: New York, New York • Queens, New York

Conditions: Colitis, Gastrointestinal Diseases, Pediatric Disorder, Pediatric Crohns Disease, Procedural Sequelae
Interventions: Low fiber diet, Standard clear liquid diet; Dietary Supplement
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 10 Years to 17 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Advanced Head and Neck Squamous Cell Carcinoma, Advanced Breast Cancer, Advanced Melanoma
Interventions: CyPep-1, Pembrolizumab 25 MG/ML [KEYTRUDA®]; Drug
Lead sponsor: Cytovation AS; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 6
States / cities: Birmingham, Alabama • Duarte, California • Detroit, Michigan + 3 more

Conditions: Cervical Cancer, Vaginal Cancer
Interventions: therapeutic allogeneic lymphocytes, cyclosporine, fludarabine phosphate, mycophenolate mofetil, peripheral blood stem cell transplantation, radiation therapy; Biological · Drug · Procedure + 1 more
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: Up to 64 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2005
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Amputation of Lower Limb
Interventions: Prosthetic foot, Physical therapy; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Kidney Transplantation
Interventions: Dose adjust group (NFAT); Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Essential Tremor
Interventions: Change DBS programming; Device
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Atrial Fibrillation (AF)
Interventions: Pulmonary Vein Isolation, vMap® + Pulmonary Vein Isolation; Procedure · Device
Lead sponsor: Vektor Medical; Industry
Eligibility: 22 Years and older
Enrollment: 423 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 12
States / cities: Jonesboro, Arkansas • Clearwater, Florida • Jacksonville, Florida + 9 more

Conditions: Fracture of Shaft of Radius and/or Ulna, Metaphyseal Fracture of Bone of Upper Limb, Fracture of Upper Limb, Level Unspecified
Interventions: No Split Cast of forearm fractures, Univalve Split Cast of forearm fractures, Bivalve Split Cast of forearm fractures; Procedure
Lead sponsor: Connecticut Children's Medical Center; Other
Eligibility: 3 Years to 12 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Respiratory Failure
Interventions: Midazolam, Normal saline, Fentanyl; Drug
Lead sponsor: Javier Gelvez, MD; Other
Eligibility: Up to 18 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Post Operative Pain, Osteoarthritis, Knee
Interventions: Bupivacaine-Meloxicam 400 Mg-12 Mg/14 mL Injectable Solution, Extended Release; Drug
Lead sponsor: Baptist Health South Florida; Other
Eligibility: 35 Years to 70 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Urinary Tract Infections
Interventions: Gentamicin, Standard of Care; Drug
Lead sponsor: Mercy Health Ohio; Other
Eligibility: 18 Years and older · Female only
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Youngstown, Ohio

Conditions: Respiratory Depression
Interventions: Not listed
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Solid Tumors
Interventions: EMD 1204831; Drug
Lead sponsor: EMD Serono; Industry
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Nephrolithiasis
Interventions: Holmium laser lithotripsy with Moses Technology, Holmium laser lithotripsy without Moses Technology; Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 171 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 6
States / cities: Phoenix, Arizona • San Diego, California • New York, New York + 3 more

Conditions: Preterm Birth, Obstetric Labor, Premature, Obstetric Labor Complications, Pregnancy Complications, Physiological Effects of Drugs, Uterine Cervical Incompetence, Anti-Bacterial Agents, Azithromycin, Cefazolin
Interventions: Azithromycin 1 gram IV, Cefazolin and indomethacin; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Chicago, Illinois • New Brunswick, New Jersey

Conditions: Premature Birth
Interventions: Seattle-PAP, Conventional bubble nasal CPAP; Device
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: Up to 30 Weeks
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Subarachnoid Hemorrhage
Interventions: Normal Saline, Nicardipine; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Park Ridge, Illinois

Conditions: Urology
Interventions: Tele-rounding in post operative care; Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Diabetes
Interventions: ATSM Intervention, GMV Intervention; Behavioral
Lead sponsor: Agency for Healthcare Research and Quality (AHRQ); Federal
Eligibility: 18 Years and older
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Epilepsy
Interventions: SPEAC System; Device
Lead sponsor: Brain Sentinel; Other
Eligibility: 22 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Lexington, Kentucky

Search by objective public record fields.

Improving Health for Patients With Chronic LBP in Rural Communities Through Telerehabilitation

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.

Ending the Epidemic Interventions in the Dental Setting - UH3

Efficacy of a Low Fiber Diet for Pediatric Colonoscopy Prep

A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers

Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer

Personalized Prosthetic Foot Prescription and Rehabilitation for Veterans With Lower Limb Loss

NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients

Atlas Predicted DBS Settings in Essential Tremor

Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

Is Univalving or Bivalving of Long Arm Casts for Forearm Fractures Necessary?

Cycling of Sedative Infusions in Critically Ill Pediatric Patients

ZYNRELEF for Pain Management in Total Knee Arthroplasty

Single Dose Aminoglycosides for Acute Uncomplicated Cystitis in the Emergency Department Setting

Clinical Utility of Capnography in the PACU( Post-anaesthesia Care Unit)

First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors

A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology

Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial

A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants

Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage

The Use of Videoconferencing for Monitoring of Patients Post Urologic Surgery

Improving Diabetes Efforts Across Language and Literacy (IDEALL)

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis